Appeals Court Revives Whistleblower Suit Alleging Drugmakers Overcharged Safety-Net Programs
A federal appeals panel has revived a whistleblower lawsuit asserting that four major pharmaceutical companies overcharged for medications intended for low-income and uninsured patients, causing financial harm to Medicare and Medicaid. The 9th U.S. Circuit Court of Appeals found the claims can proceed under the False Claims Act and sent the case ba…